Shumpei Yokota

Sapporo Kosei General Hospital — Japan

Medicine · Health Sciences

48h-index8.9kcitations403works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune and Inflammatory Disorders Research(102), Adolescent and Pediatric Healthcare(45), Kawasaki Disease and Coronary Complications(38), Inflammasome and immune disorders(36), Acute Lymphoblastic Leukemia research(34)

Publications402 total

WITHDRAWN: Ten-year follow-up of patients with refractory systemic juvenile idiopathic arthritis after the clinical trial of tocilizumab as a first biologic disease-modifying antirheumatic drug
EULAR Rheumatology Open·2025
An case of residual OTSC cut and removed with the remOVE system
Progress of Digestive Endoscopy·2025Open Access
Brucella anthropi bacteremia: Persistent bacteremia with minimal symptoms
Journal of Infection and Chemotherapy·2024· 2 cited
A case of refractory perigastrostomy dermatitis successfully treated with cosmetic puff decompression
Progress of Digestive Endoscopy·2024Open Access
POS0760 LONG-TERM PROGNOSTIC FOLLOW-UP OF PATIENTS WITH REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AFTER THE CLINICAL TRIAL OF TOCILIZUMAB AS A FIRST-LINE BIOLOGIC TREATMENT
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Modern Rheumatology·2022· 10 citedOpen Access
A Pediatrician's Perspective on Environmental Hypersensitivity: Stress Intolerance in Children of School-Absenteeism, Focusing on the Similarities with Juvenile Fibromyalgia
Indoor Environment·2022· 1 citedOpen Access
Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
Journal of Clinical Medicine·2021· 48 citedOpen Access
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients
Modern Rheumatology·2020· 21 citedOpen Access
Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study
Modern Rheumatology·2020· 3 cited
Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective
Infectious diseases News Opinions Training·2020· 13 citedOpen Access
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Lara D. Veeken·2019· 112 citedOpen Access
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
Pediatric Rheumatology·2019· 12 citedOpen Access
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018
Modern Rheumatology·2018· 48 cited
THU0599 Evaluation of efficacy and safety of canakinumab in japanese patients with systemic juvenile idiopathic arthritis in phase iii clinical trial, composed predominantly of patients with prior use of tocilizumab
Annals of the Rheumatic Diseases·2018· 2 citedOpen Access
Retraction Note: Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin
Scientific Reports·2018· 4 citedOpen Access
Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients.
PubMed·2018· 33 cited
Contents Vol. 107, 2018
Neuroendocrinology·2018Open Access
Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan
Modern Rheumatology·2017· 3 cited
Association of isochromosome (7)(q10) in Shwachman–Diamond syndrome with the severity of cytopenia
Clinical Case Reports·2017· 5 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Masaaki Mori(26), Tomoyuki Imagawa(19), Takako Miyamae(17), Syuji Takei(9), Naomi Iwata(8), Norihiro Nishimoto(8), Takuji Murata(7), Mari Miyoshi(7), Tadamitsu Kishimoto(7), Hiroaki Umebayashi(5), Shuichi Ito(5), Takuya Naruto(5), Yukoh Aihara(4), Minako Tomiita(4), Tomohiro Morio(4), Ryoki Hara(4), Tomoko Nakamura(4), Masako Kikuchi(4), Takuma Hara(4), Shigeki Katakura(3)